Our Investors


09/16/2020 at 4:15 PM Eastern
Virtual Morgan Stanley 18th Annual Global Healthcare Conference

  Listen to the replay

At Rallybio, we are focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. To date, the company has secured over $180M in financing from leading biotech investors including, but not limited to:

Mitsui Global Investment
Pivotal Bioventure Partners
Tekla Capital Management LLC